Article
Embryo biopsy and development: the known and the unknown
29 Aug 2017
Abstract excerpt
Preimplantation genetic diagnosis (PGD) has been introduced in clinical practice as a tool for selecting 'healthy' embryos before their transfer in utero. PGD protocols include biopsy of cleaving embryos (blastomere biopsy (BB)) or blastocysts (trophectoderm biopsy (TB)), followed by genetic analysis to select 'healthy' embryos for transfer in utero. Currently, TB is replacing the use of BB in the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
